 |
|
Decreased Expression of α-Synuclein, Nogo-A and UCH-L1 in Patients with Schizophrenia: A Preliminary Serum Study
Ömer Faruk Demirel, İhsan Cetin, Şenol Turan, Tarık Sağlam, Nazım Yıldız, Alaattin Duran
Psychiatry Investig. 2017;14(3):344-349. Published online 2017 May 16 DOI: https://doi.org/10.4306/pi.2017.14.3.344
|
|
Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions
Félix Javier Jiménez-Jiménez, Hortensia Alonso-Navarro, Elena García-Martín, Diego Santos-García, Iván Martínez-Valbuena, José A. G. Agúndez
Biomolecules.2023; 13(8): 1263. CrossRef Decreased serum levels of α‐synuclein in patients with schizophrenia and their unaffected siblings
Diğdem Göverti, Nihan Büyüklüoğlu, Rabia Nazik Yüksel, Hasan Kaya, Çiğdem Yücel, Erol Göka
Early Intervention in Psychiatry.2023; 17(11): 1079. CrossRef Altered Sphingolipid Hydrolase Activities and Alpha-Synuclein Level in Late-Onset Schizophrenia
Tatiana Usenko, Anastasia Bezrukova, Katerina Basharova, Galina Baydakova, Elena Shagimardanova, Nataliya Blatt, Albert Rizvanov, Oleg Limankin, Maxim Novitskiy, Natalia Shnayder, Artem Izyumchenko, Mikhail Nikolaev, Anna Zabotina, Anna Lavrinova, Darya K
Metabolites.2023; 14(1): 30. CrossRef Improper Proteostasis: Can It Serve as Biomarkers for Neurodegenerative Diseases?
Ankur Rakesh Dubey, Som Mohanlal Patwa, Sumit Kinger, Yuvraj Anandrao Jagtap, Prashant Kumar, Sarika Singh, Rohan Dhiman, Hem Chandra Jha, Amit Mishra
Molecular Neurobiology.2022; 59(6): 3382. CrossRef Psychosis‐Like Behavior and Hyperdopaminergic Dysregulation in Human α‐Synuclein BAC Transgenic Rats
Alexia Polissidis, Maria Koronaiou, Vasia Kollia, Effrosyni Koronaiou, Modestos Nakos‐Bimpos, Marios Bogiongko, Sofia Vrettou, Katerina Karali, Nicolas Casadei, Olaf Riess, Sergio P. Sardi, Maria Xilouri, Leonidas Stefanis
Movement Disorders.2021; 36(3): 716. CrossRef Astrocytes as a target for Nogo‐A and implications for synapse formation in vitro and in a model of acute demyelination
Sheila Espírito‐Santo, Vinícius G Coutinho, Rômulo S Dezonne, Joice Stipursky, Alexandre dos Santos‐Rodrigues, Carolina Batista, Roberto Paes‐de‐Carvalho, Babette Fuss, Flávia Carvalho Alcantara Gomes
Glia.2021; 69(6): 1429. CrossRef Association between the promoter haplotype of RTN4 gene and schizophrenia in a Korean population
Hae Jeong Park, Won Sub Kang, Jong Woo Kim
Psychiatry Research.2021; 299: 113841. CrossRef The Implication of Reticulons (RTNs) in Neurodegenerative Diseases: From Molecular Mechanisms to Potential Diagnostic and Therapeutic Approaches
Agnieszka Kulczyńska-Przybik, Piotr Mroczko, Maciej Dulewicz, Barbara Mroczko
International Journal of Molecular Sciences.2021; 22(9): 4630. CrossRef The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
Agnieszka Kulczyńska-Przybik, Maciej Dulewicz, Agnieszka Słowik, Renata Borawska, Alina Kułakowska, Jan Kochanowicz, Barbara Mroczko
Journal of Clinical Medicine.2021; 10(22): 5281. CrossRef The ubiquitin proteasome system and schizophrenia
Sandra Luza, Carlos M Opazo, Chad A Bousman, Christos Pantelis, Ashley I Bush, Ian P Everall
The Lancet Psychiatry.2020; 7(6): 528. CrossRef Gene expression changes related to immune processes associate with cognitive endophenotypes of schizophrenia
L. Ukkola-Vuoti, M. Torniainen-Holm, A. Ortega-Alonso, V. Sinha, A. Tuulio-Henriksson, T. Paunio, J. Lönnqvist, J. Suvisaari, W. Hennah
Progress in Neuro-Psychopharmacology and Biological Psychiatry.2019; 88: 159. CrossRef
|